[Treatment of Parkinson's disease with amantadine].
D000284:Administration, Oral; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D011379:Prognosis
D010919:Placebos; D004295:Dihydroxyphenylalanine; D000547:Amantadine
Le traitement de la maladie de Parkinson par l'amantadine.